A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies
- PMID: 12228171
- PMCID: PMC1753917
- DOI: 10.1136/ard.61.10.941
A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
